SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001564590-21-038667
Filing Date
2021-07-28
Accepted
2021-07-28 16:52:03
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-3 vktx-s3.htm S-3 885311
2 EX-1.2 vktx-ex12_9.htm EX-1.2 237533
3 EX-4.6 vktx-ex46_8.htm EX-4.6 451047
4 EX-5.1 vktx-ex51_7.htm EX-5.1 40756
5 EX-23.1 vktx-ex231_6.htm EX-23.1 3851
6 GRAPHIC gwjku2i3safr000003.jpg GRAPHIC 13142
7 GRAPHIC gwjku2i3safr000002.jpg GRAPHIC 13142
8 GRAPHIC gwjku2i3safr000001.jpg GRAPHIC 13142
  Complete submission text file 0001564590-21-038667.txt   1674238
Mailing Address 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130
Business Address 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130 858-704-4660
Viking Therapeutics, Inc. (Filer) CIK: 0001607678 (see all company filings)

IRS No.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-258231 | Film No.: 211123211
SIC: 2834 Pharmaceutical Preparations